Stethoscope head on stack of papers

Clinical Research

We continually strive to improve cancer care through clinical trials and research based on our collective experience treating patients.

Our clinical faculty engage in research on a wide variety of cancer types to provide the highest quality cancer treatment. It’s a collaborative effort. We work with cancer biologists and medical physicists to investigate ways to improve cancer care. Patients play an essential role as well by participating in clinical trials and allowing us to collect and study their tissue samples. Our retrospective research—review of the treatments and outcomes of our patients—offers insights that could provide the basis for clinical trials that drive advances in cancer care.

Radiotherapy List – Updated November 2026

CNS protocolsOpen to AccrualA Randomized Phase III Study Comparing Temporally-Modulated Pulsed Radiation Therapy (TMPRT) Versus Standard Radiation Therapy With Temozolomide for Adults With Newly Diagnosed MGMT-Unmethylated Glioblastoma (NRG-CC017)
BreastOpen to AccrualA Phase II Study of Real-Time MRI-Guided 3-Fraction Accelerated Partial Breast Irradiation in Early Breast Cancer (MAPBI) (UW18099)
GIOpen to AccrualA Phase I Study of OAR-Based, Dose Escalated SBRT with Real Time Adaptive MRI Guidance for Liver Metastases (UW18110)
GIOpen to AccrualPhase III Randomized Trial of IO-Based Systemic Treatment +/- Liver SBRT in Hepatocellular Cancer with Macrovascular Invasion (HELIO-RT) (NRGGI012)
GUOpen to AccrualPhase III Study of Local or Systemic Therapy INtensification DIrected in Prostate CAncer Patients with Post-ProstaTEctomy Biochemical Recurrence (INDICATE) (EA8191)
GUOpen to AccrualA Phase II Study of Lutetium Lu 177 Dotatate in Metastatic Prostate Cancer with Neuroendocrine Differentiation (NCI10487)
GUOpen to AccrualThe Phase III ‘High Five Trial’ Five Fraction Radiation For High-Risk Prostate Cancer (NRGGU013)
GUOpen to AccrualChemical-Shift-Encoded MRI for Active Bone Marrow Dosimetry in Radiopharmaceutical Therapy (UW26012)
H&NOpen to AccrualStudy to identify biomarkers of oral cavity cancer response to neoadjuvant immunotherapy prior to definitive surgery (UW25009)
H&NOpen to AccrualA Phase II Randomized Trial of Neoadjuvant Chemotherapy or Chemo-Immunotherapy in Patients With Recurrent/Persistent PD-L1 Enriched Squamous Cell Carcinoma of the Head and Neck Undergoing Salvage Surgery (Neopolis) (NRGHN015)
H&NOpen to AccrualRadiotherapy with Concurrent Cetuximab vs. Carboplatin and Paclitaxel in Patients with Locoregionally Advanced Head and Neck Cancer with a Contraindication to Cisplatin: A Pragmatic Phase III Randomized Trial (CONCISE) (NRGHN016)
LungOpen to AccrualPhase III Prospective Randomized Trial of Primary Lung Tumor Stereotactic Body Radiation Therapy Followed by Concurrent Mediastinal Chemoradiation for Locally Advanced Non-Small Cell Lung Cancer (NRGLU008)
LungOpen to AccrualConsolidative Use of Radiotherapy to Block (CURB2) Oligoprogression in Patients With Metastatic Non-Small-Cell Lung Cancer – A Randomized Phase 3 Trial (CCTGBR38)
Multi-siteOpen to AccrualPhase 1 Study of Y-NM600 in Patients Receiving Anti-PD-1 or Anti-PD-L1 Therapy for Metastatic Cancer (UW24136)
Multi-siteOpen to AccrualClinical Evaluation of a Treatment Planning Software and Oncology Information System for Proton Therapy (UW26028)
Multi-siteOpen to AccrualClinical Evaluation of a Treatment Planning Software and Oncology Information System for Pediatric Proton Therapy (UW26111)
Non-InterventionalOpen to AccrualProton and Photon Consortium Registry (PPCR): A Multi Center Registry of Pediatric Patients treated with Radiation Therapy (UW24091)